GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

TKNO · Jun 30, 2026

Alpha Teknova, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration

State dimensions

Filing0001193125-26-338178General Corporate
Debt relative to revenue33thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.debt_to_revenue

108.48% · OPTIONAL · VALID

Capex intensity0thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1.03% · OPTIONAL · VALID

Operating cash generation100thOwn-history percentile · N=18
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-3.87% · OPTIONAL · VALID

Revenue growth100thOwn-history percentile · N=14
Evidence method

Yoy · gp.fundamentals.revenue

18.45% · CORE · VALID

Inventory pressure28thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

56.72% · OPTIONAL · VALID

Gross margin67thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.gross_margin

40.09% · CORE · VALID

Operating margin100thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.operating_margin

-23.72% · CORE · VALID

R&D intensity0thOwn-history percentile · N=18
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

4.55% · OPTIONAL · VALID

SBC intensity6thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

5.10% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History19 statesSelf-history eligible
Dec 31, 20210/8 normalizedLevel 3Mar 31, 20220/8 normalizedLevel 3Jun 30, 20220/8 normalizedLevel 3Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/9 normalizedLevel 3Mar 31, 20230/9 normalizedLevel 3Jun 30, 20230/9 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20238/9 normalizedLevel 3Mar 31, 20248/9 normalizedLevel 3Jun 30, 20248/9 normalizedLevel 3Sep 30, 20248/9 normalizedLevel 3Dec 31, 20249/9 normalizedLevel 3Mar 31, 20259/9 normalizedLevel 3Jun 30, 20259/9 normalizedLevel 3Sep 30, 20259/9 normalizedLevel 3Dec 31, 20259/9 normalizedLevel 3Mar 31, 20269/9 normalizedLevel 3Jun 30, 20269/9 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
118.89%
Current
108.48%
Delta
-10.42%
Capex Intensity Decreased
Previous
2.00%
Current
1.03%
Delta
-0.97%
Cash Generation Increased
Previous
-30.32%
Current
-3.87%
Delta
26.46%
Growth Increased
Previous
13.09%
Current
18.45%
Delta
5.36%
Inventory Pressure Decreased
Previous
62.06%
Current
56.72%
Delta
-5.34%
Margin Increased
Previous
34.16%
Current
40.09%
Delta
5.93%
Profitability Increased
Previous
-38.80%
Current
-23.72%
Delta
15.08%
R And D Intensity Decreased
Previous
5.50%
Current
4.55%
Delta
-0.95%
Sbc Intensity Decreased
Previous
6.27%
Current
5.10%
Delta
-1.17%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Mar 31, 2026
Similarity
85%
Compared
9 dimensions
Coverage
100%
Growth 7.7 · Margin 7.8 · Profitability 17.6 · Sbc Intensity 0.3 · Capex Intensity 11.8 · Cash Generation 35.3 · R And D Intensity 11.8 · Inventory Pressure 7.5 · Balance Sheet Leverage 7.8
Sep 30, 2025
Similarity
82%
Compared
9 dimensions
Coverage
100%
Growth 18.2 · Margin 20.0 · Profitability 13.3 · Sbc Intensity 21.1 · Capex Intensity 40.0 · Cash Generation 0.0 · R And D Intensity 0.0 · Inventory Pressure 5.6 · Balance Sheet Leverage 6.7
Mar 31, 2025
Similarity
79%
Compared
9 dimensions
Coverage
100%
Growth 22.2 · Margin 12.8 · Profitability 7.7 · Sbc Intensity 32.9 · Capex Intensity 15.4 · Cash Generation 38.5 · R And D Intensity 0.0 · Inventory Pressure 10.7 · Balance Sheet Leverage 20.5
Jun 30, 2024
Similarity
79%
Compared
8 dimensions
Coverage
89%
Margin 26.7 · Profitability 20.0 · Sbc Intensity 24.4 · Capex Intensity 0.0 · Cash Generation 10.0 · R And D Intensity 0.0 · Inventory Pressure 42.2 · Balance Sheet Leverage 6.7
Dec 31, 2023
Similarity
56%
Compared
8 dimensions
Coverage
89%
Margin 41.7 · Profitability 50.0 · Sbc Intensity 81.9 · Capex Intensity 25.0 · Cash Generation 50.0 · R And D Intensity 25.0 · Inventory Pressure 2.8 · Balance Sheet Leverage 20.8
Research Graph

Related governed research

Analogous To · TKNO state analogue 2 →Compared To · In Vitro & In Vivo Diagnostic Substances peers →Analogous To · TKNO state analogue 5 →Analogous To · TKNO state analogue 3 →Analogous To · TKNO state analogue 1 →Analogous To · TKNO state analogue 4 →Has State · Alpha Teknova, Inc. →Transitioned To · TKNO Fundamental State →Transitioned To · TKNO BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · TKNO CAPEX_INTENSITY_DECREASED →Transitioned To · TKNO CASH_GENERATION_INCREASED →Transitioned To · TKNO GROWTH_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.